AAAHP business hours and after hours telephone: 61 (0)2 6108 3616. Please note: AAAHP will not return overseas calls.All overseas inquiries are to be via email or post.
Dr Peter Elepfandt will conduct the following workshop to compliment his presentation at the Conference following the workshop.
Gustafsson and colleagues found THRIVE able to keep non-obese patients with mild systemic disease well oxygenated for up to 30 minutes, extending the safe apnoeic window. Hyperventilation during pre-oxygenation had no impact on the PaCO2 at the end of apnoea compared with normoventilation. They reported an increase in PaCO2 during apnoea of approximately 0.24 kPa.min-1. This was in keeping with the study by Patel and Nouraei.
Promisingly, THRIVE appears to convey a similar benefit in healthy children by significantly prolonging the safe apnoeic time with no significant effect on CO2 clearance.
Copyright © 2002-